The hexanic extract of the Chlorophyta macroalgae Spirogyra aequinoctialis was tested in vitro for its antifungal effects against several different Candida species at four different concentrations. The huge number of these macroalgae made them an obvious choice to promote environmentally friendly economic growth and resource exploitation. Since the macroalgae studied exhibited many antifungal properties, they may be of interest to programs looking to screen cheaper and safer alternatives to currently available natural antimicrobial agents. In comparison to the other algal extracts tested, the hexanic extract showed the most activity. However, not all algae extracts demonstrated detectable inhibitory activities, and a few even promoted the growth of certain fungi. Candida albicans was one of the fungal species examined, and its reactions to the algal extract ranged from positive to negative, depending on the particular fungal and algal species used, as well as the concentration of extract. Intriguingly, compared to the patented antifungal drugs (Nystatin and Clotrimazole), the antifungal potential of several algae extracts was significantly stronger. This study provides further evidence that a hexanic extract of the macroalgae Spirogyra aequinoctialis can be used as a source of antibacterial chemical and may provide a foundation for promising future applied research into the usage of algae.